orforglipron and retatrutide 6mg GLP1-O (90 Capsules) The Future of GLPs: Orforglipron

GLP-1 drugs have been used by large shares of adults who say they have been diagnosed with diabetes (57% have ever used the drug, including 45% who are currently using), heart disease (40% ever, 29% currently), or as obese or overweight in the past five years (34% ever, 23% currently)

[DOI] [PubMed] [Google Scholar] 41.rskov C., Rabenhj L., Wettergren A., Kofod H., Holst J.J

What Refills Health Is (And Is Not) Understanding what Refills Health actually is-and what it is not-matters for anyone evaluating telehealth weight loss platforms

it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak